share_log

Essex Bio-Technology Unit's Co-Developed Drug Completes LPLV for Phase 3 Clinical Study

Essex Bio-Technology Unit's Co-Developed Drug Completes LPLV for Phase 3 Clinical Study

埃塞克斯生物科技单位共同开发的药物完成了第三阶段临床研究的LPLV。
MT Newswires ·  01/06 20:14

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发